{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:09:15Z","timestamp":1791094155570,"version":"4.1.0"},"reference-count":60,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.3892\/ol.2013.1679","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T11:49:27Z","timestamp":1384256967000},"page":"17-22","source":"Crossref","is-referenced-by-count":22,"title":["Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives"],"prefix":"10.3892","volume":"7","author":[{"given":"SHIREEN","family":"PARSAI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RICK","family":"KECK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EWA","family":"SKRZYPCZAK-JANKUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JERZY","family":"JANKUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"key":"key20180108102148_b1-ol-07-01-0017","unstructured":"American Cancer SocietyCancer Facts & Figures2013http:\/\/www.cancer.org\/research\/cancerfactsstatistics\/indexAccessed March 24, 2013"},{"key":"key20180108102148_b2-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4329\/wjr.v4.i6.241","article-title":"Epidemiology of prostate cancer and treatment remarks","volume":"4","author":"Arcangeli","year":"2012","journal-title":"World J Radiol"},{"key":"key20180108102148_b3-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"632959","DOI":"10.1155\/2012\/632959","article-title":"Polyphenols: key issues involved in chemoprevention of prostate cancer","volume":"2012","author":"Cimino","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"key20180108102148_b4-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/cncr.23009","article-title":"Prostate cancer prevention: past, present, and future","volume":"110","author":"Fleshner","year":"2007","journal-title":"Cancer"},{"key":"key20180108102148_b5-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/med.20188","article-title":"Curcumin and its analogues: potential anticancer agents","volume":"30","author":"Agrawal","year":"2010","journal-title":"Med Res Rev"},{"key":"key20180108102148_b6-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.carbpol.2012.02.036","article-title":"Curcumin\/xanthan-galactomannan hydrogels: rheological analysis and biocompatibility","volume":"93","author":"Da-Lozzo","year":"2013","journal-title":"Carbohydr Polym"},{"key":"key20180108102148_b7-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-0-387-46401-5_21","article-title":"Clinical studies with curcumin","volume":"595","author":"Hsu","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"key20180108102148_b8-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/1940-6207.CAPR-12-0410","article-title":"New perspectives of curcumin in cancer prevention","volume":"6","author":"Park","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20180108102148_b9-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/ars.2007.1769","article-title":"Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials","volume":"10","author":"Strimpakos","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"key20180108102148_b10-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1021\/jm051043z","article-title":"Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents","volume":"49","author":"Lin","year":"2006","journal-title":"J Med Chem"},{"key":"key20180108102148_b11-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1749-8546-6-31","article-title":"Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy","volume":"6","author":"Mimeault","year":"2011","journal-title":"Chin Med"},{"key":"key20180108102148_b12-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.pcan.4500399","article-title":"Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells","volume":"3","author":"Dorai","year":"2000","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20180108102148_b13-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"key20180108102148_b14-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ardp.200900319","article-title":"Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials","volume":"343","author":"Shehzad","year":"2010","journal-title":"Arch Pharm (Weinheim)"},{"key":"key20180108102148_b15-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/0008-5472.CAN-08-2367","article-title":"Curcumin disrupts the Mammalian target of rapamycin-raptor complex","volume":"69","author":"Beevers","year":"2009","journal-title":"Cancer Res"},{"key":"key20180108102148_b16-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/DMDI.2000.17.1-4.109","article-title":"The role of cyclooxygenase and lipoxygenase in cancer chemoprevention","volume":"17","author":"Cuendet","year":"2000","journal-title":"Drug Metabol Drug Interact"},{"key":"key20180108102148_b17-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-0-387-46401-5_9","article-title":"Regulation of COX and LOX by curcumin","volume":"595","author":"Rao","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"key20180108102148_b18-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/bm3017324","article-title":"Intracellular drug release from curcumin-loaded PLGA nanoparticlesinduces G2\/M block in breast cancer cells","volume":"14","author":"Verderio","year":"2013","journal-title":"Biomacromolecules"},{"key":"key20180108102148_b19-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.oraloncology.2012.09.015","article-title":"Nutraceuticals as new treatment approaches for oral cancer - I: Curcumin","volume":"49","author":"Zlotogorski","year":"2013","journal-title":"Oral Oncol"},{"key":"key20180108102148_b20-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"key20180108102148_b21-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0705659105","article-title":"Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10","volume":"104","author":"Gallego","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108102148_b22-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1016\/j.bmcl.2010.08.045","article-title":"4-methylpteridinones as orally active and selective PI3K\/mTOR dual inhibitors","volume":"20","author":"Liu","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180108102148_b23-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2005.02.019","article-title":"The C2 domain of PKCdelta is a phosphotyrosine binding domain","volume":"121","author":"Benes","year":"2005","journal-title":"Cell"},{"key":"key20180108102148_b24-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jmb.2007.05.068","article-title":"Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity","volume":"371","author":"Tochowicz","year":"2007","journal-title":"J Mol Biol"},{"key":"key20180108102148_b25-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"key20180108102148_b26-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","article-title":"Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity","volume":"11","author":"Yun","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180108102148_b27-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.bmc.2006.04.047","article-title":"Molecular modeling of non-covalent binding of homochiral (3S,3\u2032S)-astaxanthin to matrix metalloproteinase-13 (MMP-13)","volume":"14","author":"Bik\u00e1di","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"key20180108102148_b28-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728220902841045","article-title":"Nicotinic acetylcholine receptors: an overview on drug discovery","volume":"13","author":"D\u2019hoedt","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"key20180108102148_b29-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.febslet.2006.01.074","article-title":"Blind docking of drug-sized compounds to proteins with up to a thousand residues","volume":"580","author":"Het\u00e9nyi","year":"2006","journal-title":"FEBS Lett"},{"key":"key20180108102148_b30-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00894-005-0057-z","article-title":"Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the \u201cblind docking\u201d approach","volume":"12","author":"Iorga","year":"2006","journal-title":"J Mol Model"},{"key":"key20180108102148_b31-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J Computb Aided Mol Des"},{"key":"key20180108102148_b32-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1359-6446(04)03363-X","article-title":"The case for open-source software in drug discovery","volume":"10","author":"DeLano","year":"2005","journal-title":"Drug Discov Today"},{"key":"key20180108102148_b33-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbrc.2009.08.107","article-title":"Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis","volume":"389","author":"Matsunaga","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108102148_b34-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2174\/156800909788166538","article-title":"Fibrates in the chemical action of daunorubicin","volume":"9","author":"Balendiran","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180108102148_b35-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bihy.2008.07.011","article-title":"AKR1B10: A potential target for cancer therapy","volume":"2","author":"Xuyu","year":"2009","journal-title":"Bioscience Hypotheses"},{"key":"key20180108102148_b36-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2003.07.019","article-title":"mTOR integrates amino acid- and energy-sensing pathways","volume":"313","author":"Tokunaga","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108102148_b37-ol-07-01-0017","article-title":"Hitting the golden TORget: curcumin\u2019s effects on mTOR signaling","author":"Beevers","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180108102148_b38-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.phymed.2012.09.018","article-title":"Synergistic immunosuppressive effects of the mTOR inhibitor sirolimus and the phytochemical curcumin","volume":"20","author":"Deters","year":"2013","journal-title":"Phytomedicine"},{"key":"key20180108102148_b39-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-0-387-46401-5_10","article-title":"Molecular targets of curcumin","volume":"595","author":"Lin","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"key20180108102148_b40-ol-07-01-0017","first-page":"3249","article-title":"Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kappaB and mTOR signaling pathways","volume":"30","author":"Lou","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180108102148_b41-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bcp.2008.12.011","article-title":"Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats","volume":"77","author":"Conboy","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"key20180108102148_b42-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10555-011-9281-4","article-title":"Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy","volume":"30","author":"Tartour","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"key20180108102148_b43-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1535-6108(02)00157-5","article-title":"MMP9 potentiates pulmonary metastasis formation","volume":"2","author":"van Kempen","year":"2002","journal-title":"Cancer Cell"},{"key":"key20180108102148_b44-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2009.05.027","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene","volume":"288","author":"Bolignano","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180108102148_b45-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.04-2140fje","article-title":"Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes","volume":"19","author":"Masson","year":"2005","journal-title":"FASEB J"},{"key":"key20180108102148_b46-ol-07-01-0017","first-page":"57","article-title":"VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form","volume":"23","author":"Jankun","year":"2009","journal-title":"Int J Mol Med"},{"key":"key20180108102148_b47-ol-07-01-0017","first-page":"11","article-title":"PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells","volume":"20","author":"Jankun","year":"2007","journal-title":"Int J Mol Med"},{"key":"key20180108102148_b48-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"410","DOI":"10.20452\/pamw.729","article-title":"Yin and yang of the plasminogen activator inhibitor","volume":"119","author":"Jankun","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"key20180108102148_b49-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4757-4820-8_11","article-title":"Anticancer therapeutic potential of soy isoflavone, genistein","volume":"546","author":"Ravindranath","year":"2004","journal-title":"Adv Exp Med Biol"},{"key":"key20180108102148_b50-ol-07-01-0017","first-page":"563","article-title":"Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds","volume":"24","author":"Fujisawa","year":"2004","journal-title":"Anticancer Res"},{"key":"key20180108102148_b51-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ardp.200300763","article-title":"Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents","volume":"337","author":"Youssef","year":"2004","journal-title":"Arch Pharm (Weinheim)"},{"key":"key20180108102148_b52-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/biof.1072","article-title":"Molecular mechanisms of hypolipidemic effects of curcumin","volume":"39","author":"Zingg","year":"2013","journal-title":"Biofactors"},{"key":"key20180108102148_b53-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","article-title":"Antioxidant and anti-inflammatory properties of curcumin","volume":"595","author":"Menon","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"key20180108102148_b54-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1016\/j.phytochem.2004.08.008","article-title":"Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems","volume":"65","author":"Gafner","year":"2004","journal-title":"Phytochemistry"},{"key":"key20180108102148_b55-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12272-001-1183-8","article-title":"Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo","volume":"31","author":"Guo","year":"2008","journal-title":"Arch Pharm Res"},{"key":"key20180108102148_b56-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1248\/cpb.55.64","article-title":"Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors","volume":"55","author":"Handler","year":"2007","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"key20180108102148_b57-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1074\/jbc.M110.178806","article-title":"Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin","volume":"286","author":"Griesser","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108102148_b58-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1074\/jbc.M111.231969","article-title":"Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer","volume":"286","author":"Dong","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108102148_b59-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bmc.2012.11.031","article-title":"Design, synthesis and molecular docking of \u03b1,\u03b2-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity","volume":"21","author":"Xu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"key20180108102148_b60-ol-07-01-0017","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/qua.20469","article-title":"DFT and experimental studies of the structure and vibrational spectra of curcumin","volume":"102","author":"Kolev","year":"2005","journal-title":"Int J Quantum Chem"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2013.1679\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:17:45Z","timestamp":1746044265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2013.1679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,11,12]]},"published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.3892\/ol.2013.1679"],"URL":"https:\/\/doi.org\/10.3892\/ol.2013.1679","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,12]]}}}